UGT2B28 and metastatic neoplasm: Immunohistochemical staining of UGT2B28 protein expression in a TMA containing tissues from benign prostate, localized tumors, and metastatic tumors, revealed an increase in UGT2B28 expression in localized tumors vs. benign adjacent prostate tissue and metastatic vs. localized tumors (Figure 1A).